🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Palvella Therapeutics, Inc. (PVLA)
NASDAQ: PVLA · Real-Time Price · USD
146.94
+1.17 (0.80%)
Nov 20, 2026, 11:55 AM EST - Market open

Palvella Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
Selling, General & Admin
30.5415.765.943.084.16
Research & Development
39.7522.848.158.7913.88
Operating Expenses
70.2938.614.111.8718.04
Operating Income
-70.29-38.6-14.1-11.87-18.04
Interest Expense
-8.9-5.82-4.32--10.36
Interest & Investment Income
6.112.590.646.27-
Other Non Operating Income (Expenses)
-1.910.12-0.761.2-0.17
EBT Excluding Unusual Items
-74.99-41.72-18.53-4.41-28.58
Other Unusual Items
--1.123.1-
Pretax Income
-74.99-41.72-17.4318.69-28.58
Income Tax Expense
-----1.03
Net Income
-74.99-41.72-17.4318.69-27.55
Preferred Dividends & Other Adjustments
---14.81-
Net Income to Common
-74.99-41.72-17.433.88-27.55
Net Income Growth
-----
Shares Outstanding (Basic)
1311226
Shares Outstanding (Diluted)
1311226
Shares Change
46.67%405.46%24.08%-68.63%-
EPS (Basic)
-5.57-3.71-7.832.19-4.82
EPS (Diluted)
-5.57-3.71-7.832.17-4.82
EPS Growth
-----

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
EBIT
-70.29-38.6-14.1-11.87-18.04
SEC Filings: 10-K · 10-Q